You are here

VX-661

Vertex shares slip after a VX-661/Kalydeco PhIII combo study grinds to a halt

Endpoints

Mon, 08/15/16 - 09:26 pm

Vertex Pharmaceuticals

clinical trials

cystic fibrosis

Vertex Cystic-Fibrosis Drug Smacked by Burden of High Expectations

TheStreet.com

Mon, 03/23/15 - 11:26 am

cystic fibrosis

4 Biotech Reports This Month That Could Move Stocks

Investors.com

Thu, 03/19/15 - 08:15 am

Vertex Pharmaceuticals

Here's why trial data coming this month from Vertex is a big deal

Bizjournals.com

Mon, 03/16/15 - 08:57 am

Vertex Pharmaceuticals

cystic fibrosis

What to Expect From Vertex Pharma's Next Cystic Fibrosis Drug Results

TheStreet.com

Mon, 02/23/15 - 06:14 pm

cystic fibrosis

Vertex Pharma To Start Next-Gen Cystic Fibrosis Drug Studies Earlier Than Expected

TheStreet.com

Mon, 01/12/15 - 08:24 am

cystic fibrosis

5 Huge Biotech Catalysts Right Around the Corner for Top Stocks

24/7 Wall St

Mon, 07/28/14 - 12:26 pm

Arrowhead Research

Gilead Sciences

Intercept Pharmaceuticals

Vertex Pharmaceuticals

Remember Vertex? Important Cystic Fibrosis Data On Tap Next Week

TheStreet.com

Thu, 06/6/13 - 10:08 am

Vertex Pharmaceuticals

cystic fibrosis

Vertex Spikes On Phase II Data, Then The CFO Sells His Shares

Seeking Alpha

Wed, 04/24/13 - 10:23 am

Vertex Pharmaceuticals

cystic fibrosis

A Cystic Fibrosis Backup Plan

Motley Fool

Sun, 04/21/13 - 10:18 am

cystic fibrosis

Vertex Pharmaceuticals

Vertex’s post-test surge holds up as investors clamor to company

MarketWatch

Sat, 04/20/13 - 10:55 am

Vertex Pharmaceuticals

cystic fibrosis

Worth Repeating: Vertex Is The Next Gilead Sciences

TheStreet.com

Fri, 04/19/13 - 08:54 am

Vertex Pharmaceuticals